EC grants orphan drug status to BioAlliance clonidine Lauriad
The clonidine Lauriad is used to prevent radiotherapy-induced oral mucositis in patients with head and neck cancer. BioAlliance Pharma COO Judith Greciet said the European designation for clonidine
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.